nostr:npub1pu6zualylf5ut8hz9el6kzmng946wty843g7qyn6d8mc999pmrkqwau9fd this is an interesting concept, but don't get your hopes up yet. It hasn't even passed safety trials. Which means effectiveness trials haven't even begun.

Also the article seems to only have one person as a source, who "...cofounded and is a consultant, board member, and equity holder" of the company trying to profit off this.